Abstract Details
|
David G. Coughlin, MD
(University of California San Diego)
PRESENTER |
Dr. Coughlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. The institution of Dr. Coughlin has received research support from Âé¶¹´«Ã½Ó³». The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS. |
| No disclosure on file | |
| Douglas Galasko, MD (Dept. of Neurosciences, UCSD) | Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly, Inc. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognition THeraprutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Artery Therapeutics. |
| Anne E. Hiniker, MD (University of California, San Francisco) | Dr. Hiniker has nothing to disclose. |